RaySearch Laboratories (Q3 Review): EBIT beat reinforces take on conservative targets - Redeye

RaySearch’s Q3 increases our confidence in its potential for profitable sales growth, with accelerating sales drivers as we move into 2026. Though we urge a long-term perspective (given the lumpiness of the business), quarterly reports remain the main trigger to take the share toward our SEK370 base case.

Länk till analysen i sin helhet: https://www.redeye.se/research/1137458/raysearch-laboratories-q3-review-ebit-beat-reinforces-take-on-conservative-targets?utm_source=finwire&utm_medium=RSS